Portola Pharmaceuticals Inc (PTLA.OQ)

PTLA.OQ on NASDAQ Stock Exchange Global Select Market

28.35USD
24 Dec 2014
Price Change (% chg)

$0.21 (+0.75%)
Prev Close
$28.14
Open
$28.24
Day's High
$28.77
Day's Low
$28.24
Volume
27,620
Avg. Vol
149,658
52-wk High
$31.46
52-wk Low
$19.61

PTLA.OQ

Chart for PTLA.OQ

About

Portola Pharmaceuticals, Inc. (Portola) is a biopharmaceutical company developing product candidates that have the potential to represent advances in the fields of thrombosis and hematology. The Company is advancing its three wholly owned programs using biomarker and genetic approaches.

Overall

Beta: --
Market Cap (Mil.): $1,378.72
Shares Outstanding (Mil.): 48.63
Dividend: --
Yield (%): --

Financials

  PTLA.OQ Industry Sector
P/E (TTM): -- 149.43 38.63
EPS (TTM): -3.01 -- --
ROI: -55.69 -0.54 18.26
ROE: -60.38 -1.67 19.13
Search Stocks

Portola Pharma drug reverses effect of anti-clotting drugs in study

- Portola Pharmaceuticals Inc said its drug met the main goal of reversing the effect of anti-coagulant drugs in a late-stage study.

01 Oct 2014

Portola Pharma drug reverses effect of anti-clotting drugs in study

Oct 1 - Portola Pharmaceuticals Inc said its drug met the main goal of reversing the effect of anti-coagulant drugs in a late-stage study.

01 Oct 2014

Competitors

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Ford Investor Services, Inc.
$12.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks